PATENT CLAIM ANALYSIS

Application Number: 16192385
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "212040"]

Abstract:
The present invention relates to methods for treating hypercytokinemia and viral infections associated with hypercytokinemia using a mast cell stabilizing compound, optionally in combination with an antiviral agent. The invention further relates to compositions and dosage forms comprising mast cell stabilizing agents, optionally with an antiviral agent.

Claim (Index 45):
The method of  claim 6 , wherein the norketotifen or a pharmaceutically acceptable salt thereof and the additional therapeutic agent are administered in separate compositions.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 98.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15697835', '15816461', '10838338', '13793557', '15623585']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7620253286992814
- 35 USC 102 Novelty (BERT): 0.5547492876433888
- Combined Prediction Score: 0.7412977245936921
- Mean Citation Score: 247.304576
- Max Citation Score: 401.18015
- Similarity Product: 371.3221332314373

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test